MedPoints in Axial Spondyloarthropathy: A Primary Care Focus

Released On
April 24, 2020

Expires On
April 24, 2021

Media Type

Completion Time
45 minutes

Chiropractic, Pediatrics, Physiatry, Primary Care, Rheumatology

Scroll to the Bottom of this Information to Begin this Course

This activity is jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Catamount Medical Education.

Supported by an educational grant from Novartis Pharmaceuticals Corporation.

Credit Available

  • Physicians — maximum of 0.75 AMA PRA Category 1 Credit(s)

All other healthcare professionals completing this course will be issued a statement of participation.

Target Audience

This activity is designed to meet the educational needs of primary care clinicians, including internists, family practitioners and pediatricians, chiropractors, nurse practitioners, PAs, nurses, and other healthcare professionals involved in early identification, diagnosis, and ongoing care of axial spondyloarthritis (AxSpA) patients.

Program Overview

This case-based enduring activity will cover the diagnosis, treatment, and management of patients with AxSpA.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Review disease pathophysiology, epidemiology, and complications associated with diagnostic and treatment delays
  • Identify the signs and symptoms of AxSpA to support early detection and treatment decisions
  • Discuss best practices for referral of suspected AxSpA patients to a rheumatology specialist
  • Review efficacy and safety data on current and emerging novel treatment options for AxSpA


Christopher T. Ritchlin, MD, MPH

Professor and Chief
Department of Medicine
Allergy/Immunology and Rheumatology
University of Rochester Medical Center
Rochester, NY

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and Catamount Medical Education. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

All other healthcare professionals completing this course will be issued a statement of participation.

Disclosures of Conflicts of Interest

Christopher T. Ritchlin, MD, MPH

  • Consulting fees: Amgen, AbbVie, Janssen, Regeneron, Novartis, Sun, Lily, Pfizer, UCB
  • Research support: Amgen, AbbVie, UCB

Instructions for Participation and Credit

This activity is an online enduring material. There are no fees for participating and receiving credit for this activity. Successful completion is achieved by reading and/or viewing the material, studying the educational activity, and completing the post-test and the evaluation form. To answer the questions, click on your selected choice for each answer then proceed to the next question. We recommend that you print a copy of your answers before you submit them to us. Once completed, click on Submit Post-test at the bottom of the page. Your post-test will automatically be graded. You must successfully complete the post-test (score of 75% or higher) to proceed to the evaluation and obtain your certificate. Upon completion of the evaluation, your certificate will be made available immediately. Click on "View Certificate" and print the certificate for your records. If you receive a score of 74% or less, you will receive a message notifying you that you did not pass the post-test. You may retake the post-test until successful.

The estimated time to complete the activity is 0.75 hours.

This activity was originally released on April 24, 2020, and is eligible for credit through April 24, 2021.

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above

Our Policy on Privacy

Annenberg Center for Health Sciences respects your privacy. We don’t share information you give us or have the need to share this information in the normal course of providing the services and information you may request. If there should be a need or request to share this information, we will do so only with your explicit permission. See Privacy Statement and other information at

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.


The ideas and opinions presented in this educational activity are those of the faculty and do not necessarily reflect the views of the Annenberg Center and/or its agents. As in all educational activities, we encourage practitioners to use their own judgment in treating and addressing the needs of each individual patient, taking into account that patient's unique clinical situation. The Annenberg Center disclaims all liability and cannot be held responsible for any problems that may arise from participating in this activity or following treatment recommendations presented.

For questions regarding this activity, please contact Catamount Medical Education: 860-661-4157 or For accreditation questions, please contact the Annenberg Center for Health Sciences: 760-773-4500 or